Podcast TCTMD Talking Points

EVOLVE Short DAPT: 3-Month DAPT in Patients at High Bleeding Risk Treated with a Bioabsorbable Polymer-Based Everolimus-Eluting Stent

C. Michael Gibson and Ajay Kirtane review the results of this single-arm stent study.

Talking Points · Episode 99: EVOLVE Short DAPT: 3-Month DAPT in Patients

Listen to previous episodes | Download via iTunes

^{Brought to you by: Edwards Lifesciences}

TCTMD Talking Points

TCTMD Talking Points

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.